Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for tough blood cancers: first human trial of experimental pill begins

NCT ID NCT05618028

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

Summary

This is the first study in people testing an experimental oral drug called ABBV-525 for several types of advanced B-cell blood cancers, including lymphoma and leukemia. The main goals are to find a safe dose, see how the body processes the drug, and check for early signs that it might help shrink tumors. About 150 adults worldwide who have already tried other treatments will take the pill at different doses to help researchers determine the best amount for future studies.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B CELL LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Asan Medical Center /ID# 266341

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 05505, South Korea

  • Atrium Health Levine Cancer Institute /ID# 246363

    RECRUITING

    Charlotte, North Carolina, 28204, United States

  • CHRU Lille - Hopital Claude Huriez /ID# 252054

    RECRUITING

    Lille, Nord, 59037, France

  • Charite Universitaetsmedizin Berlin Campus Virchow-Klinikum /ID# 252062

    COMPLETED

    Berlin, 13353, Germany

  • China Medical University Hospital /ID# 266414

    RECRUITING

    Taichung, 40447, Taiwan

  • Fort Wayne Medical Oncology and Hematology, Inc /ID# 250113

    RECRUITING

    Fort Wayne, Indiana, 46804, United States

  • Hadassah Medical Center-Hebrew University /ID# 251441

    RECRUITING

    Jerusalem, Jerusalem, 91120, Israel

  • Hospital Clinic de Barcelona /ID# 246543

    RECRUITING

    Barcelona, 08036, Spain

  • Hospital Universitario 12 de Octubre /ID# 246538

    RECRUITING

    Madrid, 28041, Spain

  • Hospital Universitario Ramon y Cajal /ID# 246540

    COMPLETED

    Madrid, 28034, Spain

  • Hospital Universitario Vall de Hebron /ID# 245475

    RECRUITING

    Barcelona, 08035, Spain

  • IUCT Oncopole /ID# 259409

    RECRUITING

    Toulouse, Occitanie, 31059, France

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center /ID# 259872

    RECRUITING

    Indianapolis, Indiana, 46202-5116, United States

  • Institut Català d'Oncologia (ICO) - L'Hospitalet /ID# 246537

    RECRUITING

    L'Hospitalet de Llobregat, Barcelona, 08907, Spain

  • Leeds Teaching Hospitals NHS Trust /ID# 245470

    RECRUITING

    Leeds, West Yorkshire, LS9 7TF, United Kingdom

  • Liverpool Hospital /ID# 260191

    RECRUITING

    Liverpool, New South Wales, 2170, Australia

  • Memorial Sloan Kettering Cancer Center-Koch Center /ID# 245459

    RECRUITING

    New York, New York, 10065-6007, United States

  • Monash Health - Monash Medical Centre /ID# 246366

    RECRUITING

    Clayton, Victoria, 3168, Australia

  • Mount Sinai Medical Center-Miami Beach /ID# 248251

    COMPLETED

    Miami Beach, Florida, 33140-2948, United States

  • National Taiwan University Hospital /ID# 266343

    RECRUITING

    Taipei, 100, Taiwan

  • Northwest Medical Specialties - Tacoma /ID# 260376

    RECRUITING

    Tacoma, Washington, 98405, United States

  • Orange Health Service /ID# 260473

    RECRUITING

    Orange, New South Wales, 2800, Australia

  • Rabin Medical Center. /ID# 257665

    RECRUITING

    Petah Tikva, 4941492, Israel

  • START Midwest /ID# 252359

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

  • Samsung Medical Center /ID# 266415

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 06351, South Korea

  • Seoul National University Hospital /ID# 266340

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 03080, South Korea

  • Shamir Medical Center /ID# 257711

    RECRUITING

    Beer Ya'akov, Central District, 70300, Israel

  • The Alfred Hospital /ID# 248592

    RECRUITING

    Melbourne, Victoria, 3004, Australia

  • The Chaim Sheba Medical Center /ID# 251442

    RECRUITING

    Ramat Gan, Tel Aviv, 5265601, Israel

  • The Christie Hospital /ID# 250325

    RECRUITING

    Manchester, M20 4BX, United Kingdom

  • The Royal Marsden NHS Foundation Trust /ID# 250324

    RECRUITING

    London, SW3 6JJ, United Kingdom

  • Tulane Cancer Center Clinic /ID# 249586

    COMPLETED

    New Orleans, Louisiana, 70112, United States

  • UZ Gent /ID# 246462

    RECRUITING

    Ghent, Oost-Vlaanderen, 9000, Belgium

  • Universitair Ziekenhuis Leuven /ID# 246461

    RECRUITING

    Leuven, Vlaams-Brabant, 3000, Belgium

  • University Of Cincinnati Medical Center /ID# 262288

    COMPLETED

    Cincinnati, Ohio, 45219, United States

  • University of California Los Angeles Medical Center /ID# 246357

    RECRUITING

    Los Angeles, California, 90095, United States

  • University of Texas MD Anderson Cancer Center /ID# 245463

    RECRUITING

    Houston, Texas, 77030, United States

  • University of Utah Health Hospital /ID# 259924

    RECRUITING

    Salt Lake City, Utah, 84132, United States

  • Yale University School of Medicine /ID# 259081

    RECRUITING

    New Haven, Connecticut, 06510, United States

Conditions

Explore the condition pages connected to this study.

B-CELL MALIGNANCIES CHRONIC LYMPHOCYTIC LEUKEMIA DIFFUSE LARGE B CELL LYMPHOMA NON-HODGKIN'S LYMPHOMA